GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹13 Cr | ₹16 Cr | ₹0.00 Cr | ₹0.17 Cr | ₹0.41 Cr |
What is the latest Total Non-Current Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹13 Cr |
Mar2023 | ₹16 Cr |
Mar2022 | ₹0.00 Cr |
Mar2021 | ₹0.17 Cr |
Mar2020 | ₹0.41 Cr |
How is Total Non-Current Liabilities of GENNEX LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹13 Cr | -19.60 | |
Mar2023 | ₹16 Cr | 538,266.67 | |
Mar2022 | ₹0.00 Cr | -98.21 | |
Mar2021 | ₹0.17 Cr | -59.42 | |
Mar2020 | ₹0.41 Cr | - |
Compare Total Non-Current Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹323.4 Cr | -5.6% | 6.8% | -0.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -5.6% |
6.8% |
-0.9% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses